ESBA1008 Microvolume Study
NCT01849692
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Exudative Age-Related Macular Degeneration
Interventions
DRUG:
ESBA1008 solution
DRUG:
Ranibizumab
Sponsor
Alcon Research